03/2023 – Present Senior Consultant Medical Oncologist & Lead Apollo Proton Cancer Hospital, Chennai.

07/2017 – 03/2023 Head of the Department & Senior Medical Oncologist MIOT Institute of Cancer Cure, MIOT International, Chennai.

06/2016 – 06/2017 Consultant Medical Oncologist (Associate) Tata Medical Center, Kolkata, West Bengal, India.

09/2014 – 06/2016 Consultant Medical Oncologist, CBCC Cancer Center, Comprehensive Blood & Cancer Center (CBCC – India), Chennai.

11/2010 – 07/2011 Radiation Oncologist, Dept. of Radiation Oncology, Institute of Oncology, Apollo Specialty Hospital, Madurai, Tamil Nadu, India.

04/2008 – 10/2010 Clinical Oncologist, Dept. of Oncology, Indira Gandhi Govt. General Hospital & Post Graduate Institute, Puducherry, India.

06/2004 – 11/2005 Medical Officer in Emergency Room, Rotary Hospital, Chennai, Tamil Nadu, India.

03/2004 – 05/2004 Fellow in Emergency Room, Apollo Hospital, Chennai, Tamil Nadu, India.

ECMO/AWARDED AMERICAN BRACHYTHERAPY SOCIETY RESIDENT HDR FELLOWSHIP FOR THE YEAR 2009.

ONCOLOGY FELLOWSHIP AWARDS IN USA 04/2009 Awarded American Brachytherapy Society (ABS) Resident HDR Fellowship for the year 2009. Underwent clinical and didactic training in HDR brachytherapy in Texas Cancer Clinic, San Antonio, Texas, USA.

INTERNATIONAL ACADEMIC HONOURS

03/2010 Awarded International travel grant by International Gynecologic Cancer Society (IGCS) – Training at The Thomas and Dorothy Leavey Radiation Oncology Center, Long Beach Memorial Medical Center, California, USA for advanced training in Radiation Oncology.

04/2009 Awarded International travel grant by American Brachytherapy Society (ABS) for HDR brachytherapy training in Texas Cancer Clinic, San Antonio, Texas, USA.

 09/2008 Awarded International grant for attending 50th annual meeting of the AmericanSociety for Therapeutic Radiology and Oncology (ASTRO), Boston, Massachusetts, USA

RESEARCH EXPERIENCE :

10/2013 - 12/2014 Shortlisted for fellowship / research grant for conducting research in major molecular pathways in brain tumors under the initiative on the Neurosciences Clinical Research Foundation (INCRE – 2013), Department of Biotechnology, Govt. of India.

12/2012 - 12/2014 Clinical study co-investigator of “An open label, multicenter, parallel group, comparative, randomized study to compare the safety and efficacy of Trastuzumab powder for solution for infusion with Herceptin® in patients with HER2 overexpressing metastatic breast cancer” at Dept. of Medical Oncology, Madras Medical College & Government General Hospital, Chennai, Tamil nadu, India.

NATIONAL (INDIA) ACADEMIC HONOURS ORAL PRESENTATIONS

03/2014 Oral presentation in Torrent Young Scholar Award 2014 - Competition among all D.M. (Medical Oncology) super specialty post graduates across all Indian Institutes conducted in Ahmedabad, Gujarat, India - Debate Topic - “EGFR Tyrosine Kinase Inhibitors in NSCLC - Against the motion”.

04/2014 Bronze medal winner in National level talent competition - Torrent Young Scholar Award 2014 - Competition among all D.M. (Medical Oncology) super specialty post graduates across all Indian Institutes conducted in Ahmedabad, Gujarat, India. 07/2012 Oral presentation in 8th American Head and Neck Society (AHNS) held at Toronto, Canada – “Concurrent chemoradiation with weekly Cisplatin, Docetaxel and Gefitinib – A study to assess feasibility, toxicity and immediate response”.

03/2012 Oral Presentation – Best Clinical Trial Proposal Award – presented in 26th Conference of Indian Cooperative Oncology Network (ICON), Bangalore, India – “Toxicity and Efficacy analysis of Triplet combination (Docetaxel / Oxaliplatin / Capecitabine) in advanced Gastric and Gastroesophageal Malignancy”.

09/2009 Oral Presentation – Best Thesis Presentation - Submission of results of Indian Cooperative Oncology Network (ICON) trial in National meet – Awarded first prize, Rupees 50,000 in 21st Conference of ICON, Tata Memorial Hospital, Mumbai, India – “Results of Phase I trial of weekly Paclitaxel and Cisplatin with Radiation Therapy in Carcinoma Cervix”. http://oncologyindia.org/Content.aspx?Show=5AlFDZkt7143notl9qLA

09/2006 Oral Presentation – Best Project Proposal award in National conference – Awarded Rupees 500,000 for conducting a trial – 15th  Conference of Indian Cooperative Oncology Network (ICON), Trivandrum, Kerala, India – “Phase I trial of Weekly Paclitaxel as Radiosensitizer with Cisplatin and Radiation Therapy in the treatment of Carcinoma Cervix”. http://oncologyindia.org/Content.aspx?Show=5AlFDZkt7143notl9qLA

09/2005 Oral Presentation – Best paper presentation – Awarded Dr. Padam Singh Award – Association of Radiation Oncologist of India (AROI) – State Conference, September 2005, Madurai, Tamil Nadu, India – “Comparison of efficacy of 3 modalities in treatment of Carcinoma Cervix – Conventional, Hyperfractionation and Chemoradiation therapy”.

04/2000 Awarded Kishore Vyaganik Protshahik Yojna (KVPY) Scholarship, April 2000, Indian Councilof Medical Research (ICMR), New Delhi, India – “Assessment of socioeconomic aspects of 100 families in Royapuram, Chennai – A sample study in Chennai population

PUBLICATION

 1. Arun P, Senthil KR, Prasad E. Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies. Nuclear Medicine Communications. 4(4):p 276-283, April 2023. DOI: 10.1097/MNM.0000000000001661

 2. Biswas B, Dabkara D, Ganguly S, Prasad E. Consolidation chemotherapy after concurrent chemoradiotherapy in locally advanced non-squamous non-small cell lung cancer: When, whom and how much? Natl Med J India. 2016 (in press).

3. Bivas Biswas, Deepak Dabkara, Sandip Ganguly, Prasad E, and Joydeep Ghosh. “Cytoreductive nephrectomy in metastatic renal cell carcinoma in the era of targeted therapy: scientifically relevant or natural selection?”. Accepted in Journal of Clinical Oncology. Article in Press.

4. Prasad Eswaran, Kannan K. “Phase I / II trial of combination chemotherapy with Docetaxel / Oxaliplatin / Capecitabine in advanced gastric cancers”. Clinical Cancer Investigation Journal 2015; 4: 504-10.

 5. Prasad Eswaran, Velappan A, Kannan K. “Carcinoma stomach with Breast metastasis - unusual site of soft tissue deposit – A case report”. Status – Accepted for Publication - Med-ej: The official journal of The Tamilnadu Dr. M.G.R. Medical University.

6. Kannan K, Eswaran P, Ismail SR. “Management of High Risk Gestational Trophhoblastic Disease with brain metastases - A Single Institution Experience from 1996 to 2010”. Oncology, Gastroenterology and Hepatology Reports, Jan-Jun 2015, Vol 4, Iss 1, Page 1 - 3.

7. Eswaran P, Devadoss P, Narasimhan LS, Kannan K. “Monophasic Synovial Sarcoma of the Heart – A case report and Review of Literature” – Journal of Cancer Research and Therapeutics 2015; 11: 659. (Jul – Sep 2015). PMID:26458665.

8. Eswaran P, Azmi KS. “Concurrent chemoradiation with weekly Cisplatin, Docettaxel and Gefitinib: A study to assess feasibility, toxiciity and immediate response”. Journal of Cancer Research and Therapeutics 2013; 9: 392-6 (Jul – Seep 2013). PMID: 24125972.

9. Prasad E, Viswanathan P N, Faith Rangad V, Thomas Ram, Pavamani S et al. “Maximum Tolerated Dose: Results of Phase I trial of weekly Paclitaxel and Cisplatin with Radiation Therapy in Carcinoma Cervix” –Clinical Oncology, Vol 21, Iss 6, Pg 488-493 (August 2009). PMID: 19386478.

PUBLICATION (as abstracts) 1. Dabkara D, Ganguly S, Ghosh J, E Prasad, Biswas B. Metronomic cyclophosphamide in metastatic castrate resistant prostate cancer: Experience from a tertiary cancer care center. Annals of oncology 2016; 27 (Supplement 9):ix 90 [ 287 P].

2. Ganguly S, Biswas B, Dabkara D, E Prasad, Ghosh J, Bhaumik J, Midha D. Clinical profile of germ cell tumor of ovary - A single centre experience. Annals of oncology 2016; 27 (Supplement 9):ix 96 [ 305 PD].